标题
Dynamics of Minimal Residual Disease in Neuroblastoma Patients
作者
关键词
-
出版物
Frontiers in Oncology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-06-04
DOI
10.3389/fonc.2019.00455
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Prognostic value of initial bone marrow disease detection by multiparameter flow cytometry in children with neuroblastoma
- (2019) Alexander Popov et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Hijacking of Embryonic Programs by Neural Crest-Derived Neuroblastoma: From Physiological Migration to Metastatic Dissemination
- (2019) Céline Delloye-Bourgeois et al. Frontiers in Molecular Neuroscience
- Mutations of key driver genes in colorectal cancer progression and metastasis
- (2018) Dongdong Huang et al. CANCER AND METASTASIS REVIEWS
- Neuroblastoma: clinical and biological approach to risk stratification and treatment
- (2018) Vanessa P. Tolbert et al. CELL AND TISSUE RESEARCH
- Circulating tumor DNA in blood: Future genomic biomarkers for cancer detection
- (2018) Sumbal Sumbal et al. EXPERIMENTAL HEMATOLOGY
- Neuroblastoma
- (2018) Akira Nakagawara et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Prospective investigation of applicability and the prognostic significance of bone marrow involvement in patients with neuroblastoma detected by quantitative reverse transcription PCR
- (2018) Alexander E. Druy et al. PEDIATRIC BLOOD & CANCER
- Identification of the tumour transition states occurring during EMT
- (2018) Ievgenia Pastushenko et al. NATURE
- New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
- (2018) Anushka Dongre et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A conduit to metastasis: circulating tumor cell biology
- (2017) Douglas S. Micalizzi et al. GENES & DEVELOPMENT
- Neuroblastoma is composed of two super-enhancer-associated differentiation states
- (2017) Tim van Groningen et al. NATURE GENETICS
- Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries
- (2017) Valentina Boeva et al. NATURE GENETICS
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- Mechanisms governing metastatic dormancy in breast cancer
- (2017) Jürgen Dittmer SEMINARS IN CANCER BIOLOGY
- RT-qPCR for PHOX2B mRNA is a highly specific and sensitive method to assess neuroblastoma minimal residual disease in testicular tissue
- (2017) Victoria Grèze et al. Oncology Letters
- Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia
- (2017) Donald A. Berry et al. JAMA Oncology
- Tumor Heterogeneity--A 'Contemporary Concept Founded on Historical Insights and Predictions
- (2016) D. R. Welch CANCER RESEARCH
- Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patients
- (2016) Esther M. van Wezel et al. EUROPEAN JOURNAL OF CANCER
- A phase III randomized clinical trial (RCT) of tandem myeloablative autologous stem cell transplant (ASCT) using peripheral blood stem cell (PBSC) as consolidation therapy for high-risk neuroblastoma (HR-NB): A Children's Oncology Group (COG) study.
- (2016) Julie R. Park et al. JOURNAL OF CLINICAL ONCOLOGY
- Metastatic colonization by circulating tumour cells
- (2016) Joan Massagué et al. NATURE
- Highly sensitive assessment of neuroblastoma minimal residual disease in ovarian tissue using RT-qPCR-A strategy for improving the safety of fertility restoration
- (2016) Victoria Grèze et al. PEDIATRIC BLOOD & CANCER
- Metastasis as an evolutionary process
- (2016) S. Turajlic et al. SCIENCE
- Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion
- (2016) Hongxia Wang et al. Oncotarget
- Advances in the translational genomics of neuroblastoma: From improving risk stratification and revealing novel biology to identifying actionable genomic alterations
- (2015) Kristopher R. Bosse et al. CANCER
- Mechanisms of Cancer Cell Dormancy--Another Hallmark of Cancer?
- (2015) A. C. Yeh et al. CANCER RESEARCH
- TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients
- (2015) Yania Yáñez et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Bone Marrow Minimal Residual Disease Was an Early Response Marker and a Consistent Independent Predictor of Survival After Anti-GD2 Immunotherapy
- (2015) Nai-Kong V. Cheung et al. JOURNAL OF CLINICAL ONCOLOGY
- Advances in Risk Classification and Treatment Strategies for Neuroblastoma
- (2015) Navin R. Pinto et al. JOURNAL OF CLINICAL ONCOLOGY
- Whole-Genome Sequencing Identifies Patient-Specific DNA Minimal Residual Disease Markers in Neuroblastoma
- (2015) Esther M. van Wezel et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- The biology of circulating tumor cells
- (2015) K Pantel et al. ONCOGENE
- Minimal residual disease detection in autologous stem cell grafts from patients with high risk neuroblastoma
- (2015) Esther M. van Wezel et al. PEDIATRIC BLOOD & CANCER
- Epithelial–Mesenchymal Plasticity: A Central Regulator of Cancer Progression
- (2015) Xin Ye et al. TRENDS IN CELL BIOLOGY
- EMT, CTCs and CSCs in tumor relapse and drug-resistance
- (2015) Abhisek Mitra et al. Oncotarget
- FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma
- (2015) Dan Li et al. Oncotarget
- Evaluation of bone marrow as a metastatic site of human neuroblastoma
- (2014) Fabio Morandi et al. Annals of the New York Academy of Sciences
- Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
- (2014) Nicola Aceto et al. CELL
- Circulating Tumor DNA as a Liquid Biopsy for Cancer
- (2014) E. Heitzer et al. CLINICAL CHEMISTRY
- Biology, detection, and clinical implications of circulating tumor cells
- (2014) S. A. Joosse et al. EMBO Molecular Medicine
- Neuroblastoma mRNAs Predict Outcome in Children With Stage 4 Neuroblastoma: A European HR-NBL1/SIOPEN Study
- (2014) Virginie F. Viprey et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical, Biologic, and Prognostic Differences on the Basis of Primary Tumor Site in Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project
- (2014) Kieuhoa T. Vo et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
- (2014) Cassandra L Hodgkinson et al. NATURE MEDICINE
- Genomic Sequencing for Cancer Diagnosis and Therapy
- (2013) Linghua Wang et al. Annual Review of Medicine
- Cancer heterogeneity—a multifaceted view
- (2013) Felipe De Sousa E Melo et al. EMBO REPORTS
- LMO4 is an Essential Cofactor in the Snail2-Mediated Epithelial-to-Mesenchymal Transition of Neuroblastoma and Neural Crest Cells
- (2013) T. Ferronha et al. JOURNAL OF NEUROSCIENCE
- Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial
- (2013) Susan G Kreissman et al. LANCET ONCOLOGY
- Tumour heterogeneity in the clinic
- (2013) Philippe L. Bedard et al. NATURE
- Tumour heterogeneity and cancer cell plasticity
- (2013) Corbin E. Meacham et al. NATURE
- The causes and consequences of genetic heterogeneity in cancer evolution
- (2013) Rebecca A. Burrell et al. NATURE
- Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
- (2013) Irène Baccelli et al. NATURE BIOTECHNOLOGY
- Tumor metastasis: moving new biological insights into the clinic
- (2013) Liling Wan et al. NATURE MEDICINE
- Minimal residual disease monitoring in neuroblastoma patients based on the expression of a set of real-time RT-PCR markers in tumor-initiating cells
- (2013) TRI BUDI HARTOMO et al. ONCOLOGY REPORTS
- Molecular assessment of minimal residual disease in PBSC harvests provides prognostic information in neuroblastoma
- (2013) F. Chambon et al. PEDIATRIC BLOOD & CANCER
- Contribution of Multiparameter Flow Cytometry Immunophenotyping to the Diagnostic Screening and Classification of Pediatric Cancer
- (2013) Cristiane S. Ferreira-Facio et al. PLoS One
- Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
- (2013) M. A. Nieto SCIENCE
- Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
- (2013) M. Yu et al. SCIENCE
- Acquisition of epithelial–mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance
- (2013) L Chang et al. Cell Death & Disease
- Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission
- (2012) Nai-Kong V. Cheung et al. JOURNAL OF CLINICAL ONCOLOGY
- The developing cancer stem-cell model: clinical challenges and opportunities
- (2012) Louis Vermeulen et al. LANCET ONCOLOGY
- Circulating Tumor Cells and Circulating Tumor DNA
- (2011) Catherine Alix-Panabières et al. Annual Review of Medicine
- Minimal residual disease in solid neoplasia: New frontier or red-herring?
- (2011) Pierre Mordant et al. CANCER TREATMENT REVIEWS
- Methylated RASSF1a Is the First Specific DNA Marker for Minimal Residual Disease Testing in Neuroblastoma
- (2011) J. Stutterheim et al. CLINICAL CANCER RESEARCH
- The prognostic value of fast molecular response of marrow disease in patients aged over 1year with stage 4 neuroblastoma
- (2011) J. Stutterheim et al. EUROPEAN JOURNAL OF CANCER
- Minimal disease detection in peripheral blood and bone marrow from patients with non-metastatic neuroblastoma
- (2011) Yania Yáñez et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Multiple target molecular monitoring of bone marrow and peripheral blood samples from patients with localized neuroblastoma and healthy donors
- (2011) Maria Valeria Corrias et al. PEDIATRIC BLOOD & CANCER
- Controversies in clinical cancer dormancy
- (2011) J. W. Uhr et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cell-free DNA in the blood as a solid tumor biomarker—A critical appraisal of the literature
- (2010) Klaus Jung et al. CLINICA CHIMICA ACTA
- Expression of Slug Is Regulated by c-Myb and Is Required for Invasion and Bone Marrow Homing of Cancer Cells of Different Origin
- (2010) Barbara Tanno et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
- (2010) Hagop Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent Advances in Neuroblastoma
- (2010) John M. Maris NEW ENGLAND JOURNAL OF MEDICINE
- Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing
- (2010) R. J. Leary et al. Science Translational Medicine
- Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force
- (2009) K Beiske et al. BRITISH JOURNAL OF CANCER
- Detecting Minimal Residual Disease in Neuroblastoma: The Superiority of a Panel of Real-Time Quantitative PCR Markers
- (2009) J. Stutterheim et al. CLINICAL CHEMISTRY
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
- (2008) Sendurai A. Mani et al. CELL
- Exploiting Gene Expression Profiling to Identify Novel Minimal Residual Disease Markers of Neuroblastoma
- (2008) I. Y. Cheung et al. CLINICAL CANCER RESEARCH
- mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high-risk disease when measured at diagnosis
- (2008) Catarina Träger et al. INTERNATIONAL JOURNAL OF CANCER
- PHOX2BIs a Novel and Specific Marker for Minimal Residual Disease Testing in Neuroblastoma
- (2008) Janine Stutterheim et al. JOURNAL OF CLINICAL ONCOLOGY
- Minimal disease monitoring by QRT-PCR: guidelines for identification and systematic validation of molecular markers prior to evaluation in prospective clinical trials
- (2008) VF Viprey et al. JOURNAL OF PATHOLOGY
- Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia
- (2008) T Flohr et al. LEUKEMIA
- Disseminated Tumor Cells in Bone Marrow and Circulating Tumor Cells in Blood of Breast Cancer Patients: Current State of Detection and Characterization
- (2008) Sabine Riethdorf et al. PATHOBIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started